Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes

Michelle F Magee, Kelley M Baker, Stephen J Fernandez, Chun-Chi Huang, Mihriye Mete, Alex R Montero, Carine M Nassar, Paul A Sack, Kelly Smith, Gretchen A Youssef, Stephen R Evans, Michelle F Magee, Kelley M Baker, Stephen J Fernandez, Chun-Chi Huang, Mihriye Mete, Alex R Montero, Carine M Nassar, Paul A Sack, Kelly Smith, Gretchen A Youssef, Stephen R Evans

Abstract

Objective: Type 2 diabetes care management (DCM) is challenging. Few studies report meaningful improvements in clinical care settings, warranting DCM redesign. We developed a Boot Camp to provide timely, patient-centered, technology-enabled DCM. Impact on hemoglobin A1c (HbA1c), emergency department (ED) visits and hospitalizations among adults with uncontrolled type 2 diabetes were examined.

Research design and methods: The intervention was designed using the Practical Robust Implementation and Sustainability Model to embed elements of the chronic care model. Adults with HbA1c>9% (75 mmol/mol) enrolled between November 2014 and November 2017 received diabetes education and medication management by diabetes educators and nurse practitioners via initial clinic and subsequent weekly virtual visits, facilitated by near-real-time blood glucose transmission for 90 days. HbA1c and risk for ED visits and hospitalizations at 90 days, and potential savings from reducing avoidable medical utilizations were examined. Boot Camp completers were compared with concurrent, propensity-matched chart controls receiving usual DCM in primary care practices.

Results: A cohort of 366 Boot Camp participants plus 366 controls was analyzed. Participants were 79% African-American, 63% female and 59% Medicare-insured or Medicaid-insured and mean age 56 years. Baseline mean HbA1c for cases and controls was 11.2% (99 mmol/mol) and 11.3% (100 mmol/mol), respectively. At 90 days, HbA1c was 8.1% (65 mmol/mol) and 9.9% (85 mmol/mol), p<0.001, respectively. Risk for 90-day all-cause hospitalizations decreased 77% for participants and increased 58% for controls, p=0.036. Mean potential for monetization of US$3086 annually per participant for averted hospitalizations were calculated.

Conclusions: Redesigning diabetes care management using a pragmatic technology-enabled approach supported translation of evidence-based best practices across a mixed-payer regional healthcare system. Diabetes educators successfully participated in medication initiation and titration. Improvement in glycemic control, reduction in hospitalizations and potential for monetization was demonstrated in a high-risk cohort of adults with uncontrolled type 2 diabetes.

Trial registration number: NCT02925312.

Keywords: delivery of care; education and behavioral interventions; outcome research; treatment algorithms.

Conflict of interest statement

Competing interests: MFM received funding on behalf of MedStar Health Research Institute during the study period from Eli Lilly for the REWIND Study, from the Patient-Centered Outcomes Research Institute (NCT-02093234), from the National Institutes of Health (NIH DK-109503) and from Mytonomy. She served as a speaker for the American Diabetes Association and for PRIMED. KMB has no interests to declare. SJF received funding on behalf of MedStar Health Research Institute during the study period from the National Institutes of Health. CMN received funding on behalf of MedStar Health Research Institute during the study period from Eli Lilly for the REWIND Study and from the Patient-Centered Outcomes Research Institute. KS received funding from the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1-TR001409, the Agency for Healthcare Research and Quality and the National Institutes of Health (NIH DK-109503). GAY was a speaker for the American Diabetes Association during the study period. No other potential conflicts of interest relevant to this article were reported. C-CH, MM, ARM, PAS and SRE have no interests to declare.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Boot Camp study flow chart. EHR, electronic health record.
Figure 2
Figure 2
MedStar Diabetes Institute type 2 diabetes Boot Camp medication management. Algorithm and guidelines.

References

    1. Fitch K, Pyenson BS, Iwasaki K. Medical claim cost impact of improved diabetes control for Medicare and commercially insured patients with type 2 diabetes. J Manag Care Pharm 2013;19:609–20. 10.18553/jmcp.2013.19.8.609
    1. Ohkubo Y, Kishikawa H, Araki E, et al. . Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–17. 10.1016/0168-8227(95)01064-K
    1. Holman RR, Paul SK, Bethel MA, et al. . 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577–89. 10.1056/NEJMoa0806470
    1. Stratton IM, Adler AI, Neil HA, et al. . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–12. 10.1136/bmj.321.7258.405
    1. Duckworth W, Abraira C, Moritz T, et al. . Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129–39. 10.1056/NEJMoa0808431
    1. Patel A, MacMahon S, Chalmers J, et al. . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560–72. 10.1056/NEJMoa0802987
    1. Ismail-Beigi F, Craven T, Banerji MA, et al. . Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the Accord randomised trial. The Lancet 2010;376:419–30. 10.1016/S0140-6736(10)60576-4
    1. Garber AJ, Abrahamson MJ, Barzilay JI, et al. . CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY. Endocr Pract 2018;24:91–120. 10.4158/CS-2017-0153
    1. American diabetes association standards of medical care in diabetes – 2018. Diabetes Care 2018;2018:7–125.
    1. Powers MA, Bardsley J, Cypress M, et al. . Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American diabetes association, the American association of diabetes educators, and the Academy of nutrition and dietetics. Diabetes Educ 2015;41:417–30. 10.1177/0145721715588904
    1. Magee M, Bowling A, Copeland J, et al. . The ABCs of diabetes: diabetes self-management education program for African Americans affects A1c, lipid-lowering agent prescriptions, and emergency department visits. Diabetes Educ 2011;37:95–103. 10.1177/0145721710392246
    1. Magee MF, Nassar CM, Copeland J, et al. . Synergy to reduce emergency department visits for uncontrolled hyperglycemia. Diabetes Educ 2013;39:354–64. 10.1177/0145721713484593
    1. Magee MF, Khan NH, Desale S, et al. . Diabetes to go: Knowledge- and competency-based Hospital survival skills diabetes education program improves Postdischarge medication adherence. Diabetes Educ 2014;40:344–50. 10.1177/0145721714523684
    1. Strawbridge LM, Lloyd JT, Meadow A, et al. . Use of Medicare's diabetes self-management training benefit. Health Educ Behav 2015;42:530–8. 10.1177/1090198114566271
    1. Li R, Shrestha SS, Lipman R, et al. . Diabetes self-management education and training among privately insured persons with newly diagnosed diabetes--United States, 2011-2012. MMWR Morb Mortal Wkly Rep 2014;63:1045–9.
    1. Centers for Disease Control National diabetes statistics report, 2017. Available:
    1. Vigersky RA, Fish L, Hogan P, et al. . The clinical endocrinology workforce: current status and future projections of supply and demand. J Clin Endocrinol Metab 2014;99:3112–21. 10.1210/jc.2014-2257
    1. American Diabetes Association 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41:S7–12. 10.2337/dc18-S001
    1. Khunti K, Gomes MB, Pocock S, et al. . Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review. Diabetes Obes Metab 2018;20:427–37. 10.1111/dom.13088
    1. Magee MF, Nassar CM, Mete M, et al. . The synergy to control emergency department hyperglycemia program for type 2 diabetes (STEP-DM). Endocr Pract 2015;21:1227–39.
    1. Lewis VR, Benda N, Nassar C, et al. . Successful patient diabetes education in the emergency department. Diabetes Educ 2015;41:343–50. 10.1177/0145721715577484
    1. Feldstein AC, Glasgow RE. A practical, robust implementation and sustainability model (PriSM) for integrating research findings into practice. Jt Comm J Qual Patient Saf 2008;34:228–43. 10.1016/S1553-7250(08)34030-6
    1. Davy C, Bleasel J, Liu H, et al. . Effectiveness of chronic care models: opportunities for improving healthcare practice and health outcomes: a systematic review. BMC Health Serv Res 2015;15:194 10.1186/s12913-015-0854-8
    1. Bauer MS, Damschroder L, Hagedorn H, et al. . An introduction to implementation science for the non-specialist. BMC Psychol 2015;3 10.1186/s40359-015-0089-9
    1. American Diabetes Association 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41:S73–85. 10.2337/dc18-S008
    1. Nathan DM, Buse JB, Davidson MB, et al. . Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care 2009;32:193–203. 10.2337/dc08-9025
    1. Inzucchi SE, Bergenstal RM, Buse JB, et al. . Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care 2015;38:140–9. 10.2337/dc14-2441
    1. Riddle MC, Rosenstock J, Gerich J, et al. . The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080–6. 10.2337/diacare.26.11.3080
    1. American Association of Diabetes Educators AADE-7 self-care BehaviorsTM. Available:
    1. Youssef G, Ip EH, Magee M, et al. . Validity and Reliability of a (Brief) Diabetes "Survival Skills" Knowledge Test: KNOW Diabetes. Diabetes Educ 2019;45:184–93. 10.1177/0145721719828064
    1. R Core Team R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2014.
    1. StataCorp LP. College Station, tx. Available:
    1. Egginton JS, Ridgeway JL, Shah ND, et al. . Care management for type 2 diabetes in the United States: a systematic review and meta-analysis. BMC Health Serv Res 2012;12:72 10.1186/1472-6963-12-72
    1. Stellefson M, Dipnarine K, Stopka C. The chronic care model and diabetes management in US primary care settings: a systematic review. Prev Chronic Dis 2013;10:E26 10.5888/pcd10.120180
    1. Murphy ME, Byrne M, Galvin R, et al. . Improving risk factor management for patients with poorly controlled type 2 diabetes: a systematic review of healthcare interventions in primary care and community settings. BMJ Open 2017;7:e015135 10.1136/bmjopen-2016-015135
    1. American Diabetes Association 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41:S55–64. 10.2337/dc18-S006
    1. Sommerfield AJ, Deary IJ, Frier BM. Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care 2004;27:2335–40. 10.2337/diacare.27.10.2335
    1. Deichmann RE, Hebert AM, Harmeyer ED, et al. . Effects of a diabetes boot cAMP on hemoglobin A1c levels. Ochsner J 2013;13:194–9.
    1. Deichmann RE, Cazabon P, Asher T, et al. . Long-Term effects of a diabetes boot cAMP on measures of diabetic care. Ochsner J 2015;15:13–18.
    1. Spanakis EK, Golden SH. Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep 2013;13:814–23. 10.1007/s11892-013-0421-9
    1. Ricci-Cabello I, Ruiz-Pérez I, Nevot-Cordero A, et al. . Health care interventions to improve the quality of diabetes care in African Americans: a systematic review and meta-analysis. Diabetes Care 2013;36:760–8. 10.2337/dc12-1057
    1. Worth JM, Davies RR, Durrington PN. A dietitian-led lipid clinic is effective. Pract Diab Int 2006;23:221–6. 10.1002/pdi.955
    1. Senior PA, MacNair L, Jindal K. Delivery of multifactorial interventions by nurse and dietitian teams in a community setting to prevent diabetic complications: a quality-improvement report. Am J Kidney Dis 2008;51:425–34. 10.1053/j.ajkd.2007.11.012
    1. Benson GA, Sidebottom A, Hayes J, et al. . Impact of ENHANCED (diEtitiaNs Helping pAtieNts CarE for Diabetes) Telemedicine Randomized Controlled Trial on Diabetes Optimal Care Outcomes in Patients with Type 2 Diabetes. J Acad Nutr Diet 2019;119:585–98. 10.1016/j.jand.2018.11.013

Source: PubMed

3
구독하다